Stockreport

Vaxart Provides Merger Update

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administe [Read more]